Company Profiles

driven by the PitchBook Platform

NOXXON Pharma

Description

Developer of non-immunogenic alternative to antibodies for the treatment of inflammatory diseases and hematological disorders. The company develops a therapeutics named Spiegelmers that is focused for the treatment of immune cells to the kidney in diabetic patients.

1997

Founded

PUBLIC

Status

11-50

Employees

IPO

Latest Deal Type

$117M

Total Amount Raised

Description

Developer of non-immunogenic alternative to antibodies for the treatment of inflammatory diseases and hematological disorders. The company develops a therapeutics named Spiegelmers that is focused for the treatment of immune cells to the kidney in diabetic patients.

Website:

www.noxxon.com

Ownership Status

Publicly Held

Financing Status

Formerly VC-Backed

Primary Industry

Biotechnology

Primary Office

Max-Dohrn-Strasse 8-10 10589 BerlinGermany +49 (0)30 7262 470
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore NOXXON Pharma's full profile, request a free trial.

    NOXXON Pharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    NOXXON Pharma Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Aram Mangasarian Ph.DChief Executive Officer
    Sven Klussmann Ph.DChief Scientific Officer & Founder
    Matthias BaumannChief Medical Officer
    Aram Mangasarian Ph.D Chief Executive Officer
    Sven Klussmann Ph.D Chief Scientific Officer & Founder
    Matthias Baumann Chief Medical Officer

    NOXXON Pharma Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Bertram KöhlerSelfBoard Member000 0000
    Donald DeBethizy Ph.DSelfBoard Member000 0000
    Lawrence Posner MDSelfBoard Member000 0000
    Walter Wenninger Ph.DSelfChairman, Supervisory Board000 0000
    Bertram Köhler Board Member Self
    Donald DeBethizy Ph.D Board Member Self
    Lawrence Posner MD Board Member Self
    Walter Wenninger Ph.D Chairman, Supervisory Board Self
    Request full access to PitchBook